OBJECTIVE: To determine the most effective, evidence-based approach to the use of platelet transfusions in patients with cancer. OUTCOMES: Outcomes of interest included prevention of morbidity and ...
Transfusion guidelines regarding platelet-count thresholds before the placement of a central venous catheter (CVC) offer conflicting recommendations because of a lack of good-quality evidence. The ...
There is an increasing demand for single donor platelet transfusions due to intensive chemotherapy and blood stem cell or bone marrow transplantation. Platelet transfusions however are expensive and ...
Platelet transfusion in neonates and children varies widely, with donor and processing factors linked to lower platelet increments and higher transfusion burden but not to mortality or length of stay.
A group of 12 thrombocytopenic patients, ranging in age from two to fourteen years, were studied. The thrombocytopenia was due to diverse conditions (Table 1). The platelet count ranged from 3000 to ...
65.4% of hospitalized ITP inpatients did not have a bleeding episode or surgical procedure associated with their platelet transfusion. Platelet transfusions were not associated with improved clinical ...
There is a lack of evidence-based guidelines for neonatal transfusion practices as seen by the diverse RBC transfusion practices among individuals and institutions. [3,5,27,28,29,30,31,32] The US ...
Sparrow Health System in Lansing, Michigan, has won a 2018 HIMSS Davies Enterprise Award for its work using evidence-based best practices to reduce non-emergent blood transfusions. Sparrow recognized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results